Gopinath Devaraj
Associate Director & Head NR&D at Pulse Pharmaceuticals
- Role
- Associate Director & Head Nr & d at Pulse Pharmaceuticals
- Location
- Hyderabad, TG, IN
- LinkedIn followers
- 500 followers
About Gopinath Devaraj
25+ YEARS EXPERIENCE AND EXPERTISE IN NANOTECHNOLOGY, NEW CHEMICAL ENTITIES (NCEs), NOVEL DRUG DELIVERY (NDDS), NANOPHARMACEUTICALS (NPS) & GENERICS:Research Experience in formulation, process, testing, manufacturing, complete product development of following NPS, NDDS and NCEs:• Nano-pharmaceuticals: Lead Development of novel Nano-drug-products & biologicals.• New Chemical Entities : Technical-Scientific Lead on 6 NCE-molecule based pharmaceutical development projects. Products already registered in US-FDA & in market.• Liposomes: Developed Generic Liposomal Products for various Anti-Cancer, potent drugs & Bioactives • Solid Nanoparticles: Developed SLNs for Anti-Cancer & potent drugs (Lipids, biodegr’ polymers & albumin-based formulation and product development)• Nanoemulsions: Developed NEs for various potent drugs (Lipid based formulations & product development) for varied drug delivery applications (Pharmacokinetics & transdermal delivery)• Nanovesicles: Developed NVs for Anti-HIV, Anti-Cancer & other potent drugs (Developed using biologically active materials) for varied drug delivery applications (targeting, pharmacokinetics & transdermal delivery) • Nanoparticles NP & Microparticles MP: Developed novel NP & MP for various drugs, peptides, bioactives & nucleic acids Vaccines (Lipid, Polymer, Sugar & spl.Glassy Excipients)• Sustained, Controlled and Extended Release commercial drug product developmentGENERIC PRODUCT DEVELOPMENT:Experienced in ANDA’s (Abbreviated New Drug Applications), specialized in 505 (b)(2) regulatory pathway fillings, from preformulation, formulation development, analyticals, stability studies & process validation for solid dosage forms (Tablets, Hard & Soft Capsules, & Pellets), Liquids & Semi-solids, Involved in pilot & commercial production and complete documentation as per US-FDA guidelines. Products registered in US-FDA and are in Market.FEATURED PUBLICATIONS: 1. Ascorbyl palmitate vesicles (Aspasomes): formation. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 271, 95-113, 20042. 1-O-Alkylglycerol vesicles (Algosomes): their formation and. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 246, 187-197, 2002SOME PATENTS:1. EXTRUDED CHEWABLE FORMULATION COMPRISING OF BOUND WATERPatent number: 95•••85; Type: GRANT; Filed: March 8, 2016; Date: March 21, 2017 2. COMPOSITIONS OF GRAPIPRANT AND METHODS FOR USING THE SAMEType: GRANT, Patent number: 11••••21; Date: June 28, 20223. COMPOSITIONS AND METHODS OF USE OF AN INAPPETANCE-CONTROLLING COMPOUNDType: GRANT, Patent number: 11••••92; Date: August 17, 2021
Experience
Associate Director & Head Nr & d
Mar 2023 — Present · Hyderabad, IN
Education
Savitribai Phule Pune University
Masters Degree (M.Pharmacy), Pharmaceutics, NDDS
1995 — 1996
Kakatiya University (University College of Pharmaceutical Sciences)
PhD, Pharmaceutics, Drug Delivery, NDDS
1999 — 2004
University of Otago
Post Doctoral Fellow, Pharmaceutical Sciences
Skills
- Generic Programming
- Pharmaceutics
- Chromatography
- Anda
- Process Simulation
- Formulation
- Pharmaceutical Industry
- Sop
- Characterization
- Analytical Chemistry
- Novel Drug Delivery Systems(Ndds)
- Glp
- In Vivo
- Nces
- Technology Transfer
- Pharmaceutical Research
- Pharmacokinetics
- Pharmacodynamics
- Good Laboratory Practice (Glp)
- Hplc
- R&D
- Regulatory Affairs
- Nanotechnology
- Drug Delivery
- Vaccines
- High-Performance Liquid Chromatography (Hplc)
- Gmp
- In Vitro
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.